ClinicalTrials.Veeva

Menu

Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France (F3S2)

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Enrolling

Conditions

Corneal Dystrophies

Treatments

Other: Collection of data
Diagnostic Test: Histology
Genetic: Genotyping

Study type

Observational

Funder types

Other

Identifiers

NCT05742321
22CH354
2022-A01217-36 (Other Identifier)

Details and patient eligibility

About

The pathophysiology of the most common corneal endothelial dystrophies (Fuchs' Corneal Endothelial Dystrophy, FECD) is beginning to be dismembered. There is a significant heterogeneity in the clinical forms and the investigators have just highlighted a great diversity of histological forms that seem to define distinct groups.

Full description

The most frequent genetic abnormalities have been published since 10 years and can now be easily searched. This study is going to analyze the relationships between clinical, histological and genetic forms in a large population to better understand how histological abnormalities are formed.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • affiliated with or entitled to a social security scheme
  • Consent form to participate in the study signed
  • with an FECD certified by slit lamp examination
  • requiring an endothelial keratoplasty

Exclusion criteria

  • Patients under guardianship or curators

Trial design

500 participants in 1 patient group

Patients with FECD
Description:
Patients with Fuchs Endothelial Corneal Dystrophy (FECD). They will have a collection of data and a blood sample
Treatment:
Genetic: Genotyping
Diagnostic Test: Histology
Other: Collection of data

Trial contacts and locations

1

Loading...

Central trial contact

GILLES THURET, MD-PhD; PHILIPPE GAIN, MD-PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems